We report here the discovery of HMBP, a protein in nuclei of human T-helper lymphocytes and other human cell types, which binds with enhanced affinity to a promoter element in the HIV-1 long terminal repeat when that element is methylated at CpGs, the target site of the human DNA methyltransferase. This promoter element contains three (degenerate) binding sites for Sp1, a general activator of transcription. Gel shift assays and footprinting experiments indicate that HMBP binding overlaps two of these methylated Sp1 sites. Although HMBP binds these methylated Sp1 sites, it does not bind consensus Sp1 sites. Competition studies, differences in binding site specificities, binding conditions, and, in some cases, chromatographic separation further distinguish HMBP from Sp1 and from each of four previously identified methylated-DNA binding proteins. HMBP binds hemimethylated DNA in a strand dependent manner. These binding characteristics suggest that HMBP may recognize newly replicated DNA and thereby play a role in differentiation. If HMBP is able to compete with Sp1 for binding at methylated, non-consensus Sp1 sites in vivo and repress transcription, it may play a role in AIDS latency.
INTRODUCTION
Vertebrate DNA is methylated at cytosines in the relatively rare dinucleotide CG. Although CGs are scarce in coding sequences, gene promoters are usually enriched in CGs. There is overwhelming correlative data between the presence of methylated promoter sites and transcriptional repression. Furthermore, experimental demethylation by 5'azacytidine has been shown to activate gene expression. The clearest demonstrations that DNA methylation represses transcription have been transfection experiments where expression of genes with methylated promoters was greatly repressed relative to those with unmethylated promoters. (The role of DNA methylation in gene repression is reviewed in 1-7).
DNA methylation is thought to repress transcription by one or both of two mechanisms. In one mechanism, DNA methylation masks the recognition site of a sequence-specific binding protein which acts as a trancriptional activator. This has been shown for a number of rra/u-activating factors including the myc/myn heterodimer (8) , the cAMP responsive element binding protein CREB (9) , NFxB (10), AP2 (11) , EF2 (12, 13) , MLTF (14) , EBP-80 (15) , and a factor required for tyrosine aminotransferase expression (16) . In the second mechanism, DNA methylation creates a recognition site for a transcriptional repressor. Such a repressor might prevent binding of a trancriptional activator by competing for the same binding site or prevent binding of the initiation complex. Transcription decreases with methylation density at proximal promoters (17 -19) . DNA methylation at some promoters, including the HTV-1 LTR (19) , represses transcription indirectly consistent with the requirement for a methylated-DNA binding protein (17) (18) (19) (20) (21) . Thus far, two methylation-specific binding factors have been shown to repress transcription, MeCPl (20) and MDBP-2-H1, a species of avian histone HI (21) .
DNA methylation may mediate repression of HIV-1 in latently infected CD4+ cells. In the early stages of AIDS, many of these cells are latently infected with HTV-1. Viral DNA is present but is not being transcribed (22, 23) . Transcription of HTV-1 is controlled by promoter sequences contained in its 5' long terminal repeat (LTR). In cells stably transfected with plasmid constructs where the HTV-1 promoter controls expression of the reporter gene for chloramphenicol acetyl transferase (CAT), demethylation of the HTV-1 promoter by the methylase inhibitor 5-azacytidine activates transcription of the associated CAT gene (24) . Methylation of the LTR in LTR-CAT constructs by prokaryotic methylases represses transcription in transfection assays (25) . Moreover, methylation at die CG between the binding sites for NFxB, precludes binding by NFxB (10) , an activated transcription factor in lymphocytes. The NFxB sites and the three Spl sites comprise the HTV-1 proximal promoter, a region of predominant importance in the activation of HIV-1 transcription (26) .
The transcription factor Spl is required for the expression of many genes including those under the control of the HTV-1 promoter (27) . The highest affinity binding sites for Spl contain a CG dinucleotide (28, 29) . The three Spl sites in the HIV-1 promoter each contain a CG dinucleotide. Mutation of all three sites greatly decreases transcription (27) . Although Spl binds DNA and activates transcription in vitro even when the binding site is CG methylated (30, 31, 32) , transcription in vivo is inhibited when Spl sites are methylated (31, 33) .
In this paper we report the identification and binding characteristics of a putative repressor protein which preferentially binds sites in the Spl region of the HIV-1 promoter when the CGs in this sequence are methylated. HMBP (HTV-1 methylated DNA binding protein) is present in nuclear extracts prepared from cultured human T-helper cells and HeLa cells and can be distinguished from Spl and each of the four previously characterized methylated DNA binding proteins.
MATERIALS AND METHODS Cell culture and nuclear extracts
HuT 78 cells (obtained from the ATCC and from Dr Robert Gallo through the AIDS Research and Reference Reagent Program, NIAID) and HPB-ALL cells (34) were cultured as suppliers recommend or in AIM V (Bethesda Research Laboratories). Nuclear extract was prepared as described in (35) or as described in (34, 36) but in buffer HDIE: 30 mM HEPES (pH 7.5), 0.25 % myoinositol, 0.25 mm EDTA, 5mm PMSF, 0.8 jtg/ml pepstatin A, 1 mM DTT and 10 % glycerol as described (30, 32) , dialysed in buffer HDIE with 0.2 M KC1 and fractionated by Bio-Rex 70 (BioRad) chromatography. The 0.2M KC1 flow through fraction contained HMBP. This flow-through was further fractionated for gel shifts with monomethylated probes: For the gel shift assay shown in Figure 4 , a 25 mM-200mm KC1 fraction containing HMBP was used. (The 25 mM wash contained a methylated DNA binding activity that did not bind fully methylated 43-mer.) HeLa cell nuclear extract was obtained from G. Gilmartin prepared as described (37) . Although HMBP is only 2 fold purified by Bio-Rex chromatography over crude nuclear extract, this step effectively removes other proteins which bind the 43-mer on a gel shift assay. Fractions eluted with buffer containing 0.4 M KC1 contained Spl. Nuclear extract was precipitated with 50% ammonium sulfate and used for wheat germ agglutinin affinity chromatography as described (38) .
CAT assay The HTV-1 LTR-CAT plasmid, pBenn-CAT, was obtained from Malcolm Martin (39) . After restriction by Bam HI and Pst I, a 3300 bp fragment containing the entire LTR and CAT gene was methylated by Steven Smith and Julie Kan (City of Hope Medical Center, Duarte CA) with methylase they purified from human placenta (40) . We transfected the LTR-CAT 3300 bp fragment by electroporation into Hut 78 cells as described (41) , and assayed for CAT activity after 72 h. as described (42) except that enzyme reaction was allowed to proceed overnight. Overnight assay allows detection of CAT activity in the absence of HIV tat activity. CAT activity was quantified using a Betascope model 603 blot analyser (Betagen Corp.) and is reported as % of total chloramphenicol converted to acetylated products.
Oligonucleotides, gel-shift probes, and proteins Oligonucleotides were synthesized on an Applied Biosystems model 392 synthesizer using 5-methyldeoxycytosine and the other four bases as phosphoramidite derivatives. After gel purification, oligonucleotides were labeled at the 5' end of either the top or bottom strand with T4 polynucleotide kinase and annealed with 50% excess of unlabeled, complementary strand. This ensured that gel shift bands did not contain single stranded DNA probe. Dimerized and multimerized competitor DNAs were prepared by ligation of phosphorylated, annealed, sticky-ended, oligonucleotides using T4 DNA ligase with buffer supplied by the manufacturer (US Biochemicals). DNA samples were analysed by gel electrophoresis before use. Histone HI was purchased from Boehringer Mannheim and shown by SDS-PAGE to be intact. Spl(15 ng protein//d) was purchased from Promega.
Gel shift analyses
Binding reactions contained 0.07-0.7 ng kinase-labeled, doublestranded methylated, hemi-methylated, or unmethylated 43-mer, 80-500 fold excess poly (dl-dC) (Pharmacia), 75 mM KC1, 10 mM Tris-HCl, pH 7.5, 0.25 mM EDTA, lmM DTT, 10% glycerol, varying amounts of competitor DNA, and 2-4 ng of dialysed nuclear extract. Protein concentration was determined by the Bradford assay (BioRad) with IgG as standard. After 20' on ice, binding reactions were electrophoresed through 5 % PA-GE in 0.5 XTBE for 1 hr at 15 mA at RT. Gels were dried and autoradiographed with an intensifying screen at -80°C. Radioactivity in bands in dried gels was quantified by a Betascope model 603 blot analyser (Betagen Corp.). For quantifying competition experiments, after subtracting background, the radioactivity in competed HMBP complexes was computed as a percentage of die radioactivity in non-competed HMBP complexes in the same experiment. Competition is plotted as a function of the mass excess of competitor DNA.
Two-dimensional DNase 1 footprinting
94-mer top strand: 43-mer was ligated into the Sma I site in die polylinker of pBS plasmid (Stratagene) and cloned in JM83 cells. Purified plasmid DNA was cut with Eco RI, methylated with excess SssI methylase (New England Biolabs) in buffer containing EDTA as recommended by die supplier and an aliquot analysed for completeness of methylation by digesting with Hpa n. Plasmid DNA was then cut with Hind III to release a 94 bp fragment containing the 43-mer. Labeling at the 3' end of the top strand (5' to 3' reading towards the start of transcription in the HIV 1 LTR) was done at the Hind HI site with Klenow and [a] 32 ? dCTP. 43-mer top or bottom strand was kinase labeled before annealing. After scaled-up gel shift binding reactions were performed, reactions were made 1 mM in CaCl 2 and treated with 2.9 ng DNase I (5 ng/^1) for 1' at RT for the 94-mer and at 10-80 ng//tl for 43-mer and stopped with EDTA before gel electrophoresis. DNAs from bodi the HMBP shifted bands and from the free probe bands were isolated from the gel and purified. Equal cpm of DNAs were electrophoresed through a 10% (94-mer) or a 17 % sequencing gel (43-mer) before autoradiography.
Two-dimensional DMS footprinting
43-mer was kinase-labeled in the top strand before annealing in a HEPES buffer. (The bottom strand is too G-poor for DMS cleavage analysis.) After a scaled-up binding reaction, 3 /tl DMS was added to the 150 fd vol binding reaction containing 250 ng protein and incubated at 0°C for 2.5'. The reaction was stopped with 0.2 M 2-mercaptoethanol before electrophoresis. DNAs from the HMBP shifted band and from the free probe band were isolated from die gel and purified. Equal cpm of DNAs were electrophoresed through a 10% sequencing gel before autoradiography.
RESULTS

DNA methylation by the human methylase represses transcription regulated by the HTV-1 LTR
An LTR-CAT reporter construct was methylated in vitro by the laboratory of S.Smith using DNA methylase they purified from human placenta (40) . Approximately 12% of the CGs became methylated. After duplicate transfections into cultured Human T helper lymphocytes in parallel with unmethylated constructs and mock transfections without plasmid, cell extracts were analysed for CAT activity. Figure 1 shows that methylated constructs expressed very low levels of CAT activity not much more than mock transfection controls, whereas unmethylated constructs expressed high levels of CAT activity in the same experiment. Since methylation of coding sequences has no effect on transcription (1-7), these transfection experiments suggest that methylation of the HTV-1 LTR by the human methyltransferase represses transcription of an associated gene.
A nuclear factor preferentially binds the HTV-1 Spl region when Spl sites are methylated
We used gel shift assays to determine if nuclear extracts from cells capable of being infected by HTV-1 contained factors which discriminate between methylated and unmethylated HTV-1 promoter sequences. We found a methylation-specific binding factor, HMBP With calf thymus DNA or E.coli DNA as non specific competitor DNA, there is no HMBP gel band (not shown). This implies that calf thymus DNA and E.coli DNA contain (methylated) sequences which bind HMBP. HMBP is protease sensitive and RNase resistant (not shown). Quantitation of HMBP binding in this and other gel shift experiments shows 4-7 fold preference for methylated 43-mer versus unmethylated 43-mer.
HMBP footprints the Spl region of the HTV-1 LTR
In order to more precisely determine the DNA sequence bound by HMBP, DNase I and DMS footprinting experiments were used to map DNA sequences in the LTR which are protected from these reagents by HMBP binding. After treatment with either DNase 1 or DMS, binding complexes were isolated from gels before the DNAs were analysed by sequencing gels. Twodimensional footprinting insures that only complexes due to HMBP binding are analysed. DNase 1 was used to footprint HMBP binding to both the top and bottom DNA strands (5' to 3' going toward the transcription start site in the HTV-1 LTR as shown in Figure 2 ) of the methylated Spl region of the HTV-1 LTR. For Figure 3A , the 43-mer was cloned into the multicloning region of a plasmid, methylated at every CG, cut out of the plasmid as a 94-mer and the top strand 3' end-labeled at a site distal to the end of the 43-mer. This fragment was used as the binding probe for the Bio Rex70 flow through fraction of nuclear extract containing HMBP. After binding, the reaction was treated with DNase 1 and then gel shifted. As shown in Figure 3A , there is a DNase 1 hypersensitive site near the 5' methylated cytosine (5' M), and a protected region encompassing the 3' M and extending into plasmid sequences. Other two-dimensional footprinting experiments were done with the methylated 43-mer. The top strand of the 43-mer was 5' end-labeled before the binding reaction and DNase 1 footprinting shown in Figure 3B . In the lighter exposure (the left side), there is partial protection of sequences at the 5' M and a footprinted region encompassing the 3' M which is best observed in the darker exposure (right side of Figure 3B ). Although DNase 1 cuts are fainter near the end of the fragment, protection of the complex relative to the free DNA terminates after the 3' M. Figure 3C shows that the methylated CG closest to the TATA box is the methylated site that is best protected from DNase I digestion in the bottom strand. DMS protection experiments were used to map the HMBP protected sites in the G-rich, top strand ( Figure 3D ). HMBP protects the 43-mer from DMS cleavage most clearly at the 3' methylated CG in the top strand although a difference at the 5' methylated cytosine can be detected ( Figure 3D ). There appears to be no footprinting of the middle methylated CG in either the top or bottom strand. These results are diagramed in Figure 3E . When we used commercially obtained Spl to footprint this region, DNase I protection was detected over the entire 43-mer (not shown) as has been shown by others (27) .
HMBP preferentially binds hemi-methylated DNA when the bottom strand is methylated
We tested, by gel shift assays, whether HMBP could bind the 43-mer when only the top strand or only the bottom strand is Nonetheless, HMBP must contact the top strand when both strands are methylated, since HMBP protects sequences in this strand from DNase I digestion (See Figure 3) .
HMBP fails to preferentially bind the 43-mer if only one site is methylated
We tested whether HMBP could bind the 43-mer containing only a single methylated site by gel shift assays. Figure 5 shows that HMBP binds no better to 43-mer when any one of the CGs is methylated than when no sites are methylated. Compare lanes 2, 3, and 4 to lane 1 (all three sites methylated) and to lane 5 (no sites methylated) in Figure 5 .
The HTV-1 methylated DNA binding factor is not Spl Spl, unlike HMBP, does not preferentially bind Spl sites when diey are methylated. However, since the 43-mer used for these assays contains three binding sites for Sp 1, and since the HMBP footprint overlaps widi at least two Spl sites (Figure 3) , it was important to determine whether this binding factor is a species of Spl. We found that column chromatography of T-cell nuclear extract dirough a weak cation exchange resin (Bio-Rex 70) separates Spl, and other proteins which bind the 43-mer, from HMBP ( Figure 5 , compare lane 2 to lane 7). Moreover, while a mediylated Spl consensus binding site, GGGGMGGGG, in monomer or dimer form, competes for Spl binding, it does not compete for binding by HMBP ( Figure 6A ). Wheat germ agglutinin affinity (WGA) chromatography (38) also separates HMBP from Spl ( Figure 6B ). WGA fails to retain HMBP. We conclude from these differences that HMBP and Spl are different proteins. Moreover, the failure of the consensus Spl site to bind HMBP explains the lack of footprinting by HMBP over the middle Spl site In die HIV1 LTR since this site is most similar to the consensus SP1 sequence.
HMBP is not MDBP-2-H1, an avian histone HI which binds methylated DNA MDBP-2-H1, a methylated-DNA binding protein, has been shown to be a chicken histone HI subspecies (43) . Purified, unfractionated chicken histone HI also preferentially binds methylated DNA sequences (43) . However, mammalian histone H1 does not preferentially bind methylated DNA sequences but when denatured, mammalian histone HI binds sequences irrespective of their methylation status (44) (45) (46) . We were unable to detect binding by purified, undegraded, native bovine histone HI to methylated 43-mer under gel-shift conditions in which HMBP binds (not shown). We estimate mat less than 0.1 ng of HMBP complex is present in a gel shift band. Since up to 10 ngs of HI were used in this experiment and no detectable binding was discerned, we conclude that HMBP is not histone HI nor an HI subspecies.
HMBP is distinct from methylated-DNA binding proteins MDBP-1, MeCPl, and MeCP2
MDBP-1 is a methylated DNA binding protein which binds a family of related methylated sequences and also binds some unmethylated sequences (47) (48) (49) (50) (51) . One high affinity binding site for this factor is a 14 base pair sequence with three methylated cytosines and a 4 base pair overhang (see Figure 7) . As a monomer, the 14-mer competes poorly with the HTV-1 LTR 43-mer for binding to HMBP (Figure 8 ). Therefore HMBP is unlikely to be the same protein as MDBP-1. When multimerized, methylated 14-mer becomes a high affinity binding site for MeCPl, a methylated DNA binding protein which binds sites containing at least 12 methylated CGs regardless of their sequence (44) . Figure 8 shows that when the 14-mer is fold excess (in ng relative to probe), unlabeled, competitor DNAs. These results are a compilation of at least two experiments for each competitor DNA. All gel shift assays also contained poly (dl-dC) double stranded DNA in 500 fold mass excess as non-specific competitor DNA.
multimerized (to a weight-average length of 180 base pairs), it competes for HMBP binding but less well than methylated 43-mer competes for HMBP binding (Compare Figure 8 , lanes 9-12 with lanes 15-18). Competition by methylated, multimerized 14-mer is probably due to the sequence, GGMG-A, which is present in the 14-mer and is part of a direct repeat in the 43-mer (See Figure 3E) . Several other lines of evidence indicate that HMBP is probably not the same protein as MeCPl. MeCPl requires at least 12 methylated CGs for binding (44) while HMBP binds to a sequence with three methylated CGs ( Figure  2B ). Furthermore, MeCPl forms such a large complex with methylated DNA that binding reactions must be resolved on agarose gels (44) . In addition, MeCPl binds DNA in 10 mM MgCl 2 (44) , whereas HMBP binding is inhibited in the presence of Mg + + . MeCP2, another recently described methylated DNA binding protein, like MeCPl, fails to discriminate among methylated DNA sequences (45, 46) . Furthermore, unlike HMBP ( Figure  4 , lane 2), neither MeCPl nor MeCP2 bind hemi-methylated DNA significantly (44, 45) . Table 1 summarizes the binding site differences among the known methylated DNA binding proteins.
The competition by various methylated binding sites and by both unmethylated and methylated 43-mer for binding to HMBP is quantified in Figure 7 . Competition by methylated monomeric and dimeric Spl consensus sequences show no significant HMBP binding ( Figure 5A ) and are not quantified.
DISCUSSION
We describe here the binding characteristics of a newly discovered protein, HIV-1 methylated DNA binding protein (HMBP). HMBP preferentially binds sites in the Spl region of die HTV-1 promoter when the CGs are methylated. However, on the basis of differing DNase I footprints, differing affinities for unmethylated binding sites, separation by two different chromatographic fractionation schemes (WGA and Bio-Rex 70), and differences in binding site specificities as revealed by competition with methylated Spl consensus binding sites, we conclude that HMBP and Spl are different DNA binding proteins. HMBP binding protects two sites in the HIV-1 LTR that overlap direct repeats of G A/TGGMGA/TG. Since these sites differ gready from the consensus Spl site, GGGC/MGGG, the inability of die methylated Spl consensus site to compete for HMBP binding is explained. Whether HMBP will bind to other mediylated, non-consensus Spl sites or odier sequences awaits determination with a purified protein by a target detection assay such as has been used widi Spl (28, 29) .
Since HMBP binds at two sites overlapping direct repeats in the 43-mer, we propose that HMBP binds to diese direct repeats as a dimer. This would explain our finding that HMBP activity is separable from a methylated DNA binding activity that binds the 43-mer when only one site is methylated (Shao and Pratt, in preparation). In our binding studies, HMBP binds methylated DNA with 7 fold increased affinity over unmethylated DNA. Methylation specificity is equivalent to a conservative change of only one base pair per binding site. Other binding conditions, or in vivo conditions, may change the binding differential between mediylated and unmethylated substrates. It may be that these differences in binding efficiency are sufficient for the functions served by HMBP binding in vivo.
HMBP has been found in nuclei of two human CD4+ T cell lines and in HeLa cells. Other cell types have not yet been investigated.
Four different proteins which preferentially bind methylated DNA sequences have been described: MDBP-1 (47-51), MDBP-2-H1 (21, 43), MeCPl (44) , and MeCP2 (45) (46) . Binding site specificities (Table 1) , gel-shift conditions, molecular weights [HMBP is close to 300 Kd by sizing column and has several large bands by southwestern analysis (Shao, Joel and Pratt, in preparation)] and odier characteristics indicate that HMBP differs from tiiese proteins and is therefore a newly discovered methylated DNA binding protein. However, until diese proteins are purified and tested under exactly the same conditions, we cannot be sure they are unrelated.
HMBP preferentially binds hemi-mediylated DNA only when the bottom strand is mediylated. This suggests the intriguing possibility of a role for HMBP in cell differentiation. Immediately after DNA replication, a high affinity, methylated recognition site for HMBP would be present at only one side of the replication fork. This offers a way for differentiating mechanisms to discriminate between two daughter DNA molecules immediately after DNA synthesis if HMBP binds before maintenance mediylation occurs.
HMBP may be involved in HIV-1 latency. This is suggested by studies showing that retroviruses preferentially integrate into methylated host DNA sequences (52) ; that integrated retroviral DNA becomes methylated, is transcriptionally repressed and thereafter remains latent for varying periods of time in infected cells (53) ; and that HIV-1 LTR regulated transcription can be activated by a demediylating agent (24) . If HTV-1 proviral DNA becomes methylated after integration into die host genome, if methylation then allows high affinity HMBP binding to the HIV-1 promoter, and if this then precludes binding by Spl, transcription would be repressed and AIDS latency would result.
